Developing a Proactive Strategy for Non-Icans Neurotoxicity in Cilta-Cel Therapy: Bridging Education, Monitoring, and Early Intervention

Key Points

• Neurotoxicity was effectively addressed through early intervention strategies, improving patient outcomes.
• Monitoring protocols identified biomarkers associated with neurotoxicity in cilta-cel therapy.
• Analysis of retrospective data across multiple institutions was utilized to assess intervention efficacy.
• This proactive strategy may enable better management of cilta-cel therapy's side effects, but further validation is needed.